Home › Jobs › Definium Therapeutics

Associate Director, Pharmacovigilance Operations

Definium Therapeutics · Remote (US) · Posted November 17, 2026 (2 days ago)

Apply on Definium Therapeutics’s siteFill the application with AutoFillSee your fit for this role

Job description

Definium Therapeutics is a late-stage clinical biopharmaceutical company and our mission is to forge a new era of psychiatry by applying scientific rigor to psychedelics, with the goal of developing accessible treatments that unlock healing at scale.

Our lead product candidate, lysergide tartrate (our proprietary orally disintegrating tablet form of lysergide (LSD) D-tartrate), represents a highly differentiated, potential best-in-class opportunity for patients suffering from generalized anxiety, major depressive disorder, and posttraumatic stress disorder. Our early stage pipeline includes DT402, the R-enantiomer of MDMA and is under development to target the core symptoms of autism spectrum disorder (ASD), specifically addressing social communication challenges.

Guided by the recognition that patients deserve more than better, Definium is relentlessly advancing a new generation of therapeutics intended to address the underlying causes of psychiatric and neurological disorders. By turning evidence into impact, Definium aims to change the trajectory of today’s mental health care crisis and enable a healthier future. Headquartered in New York, Definium Therapeutics trades on Nasdaq under the symbol DFTX.

Together we are moving psychiatry forward—beyond better, into a boundless future. Join us!

Definium Therapeutics, Inc. is seeking a Associate Director, Pharmacovigilance Operations to play a key role in setting and executing on departmental strategy, as well as managing the day-to-day functioning of the Pharmacovigilance department. The incumbent will be responsible for overseeing departmental activities associated with investigational products. This role provides an outstanding opportunity to work in a matrix environment and collaborate with colleagues from Biometrics, Clinical Development, Clinical Operations, Medical Affairs, and Regulatory Affairs.

Responsibilities

Contribute to the development and execution of Pharmacovigilance Operations strategy and manage the day-to-day operations of the department for investigational products

Oversee the intake, processing, medical coding, quality review, and timely reporting of individual case safety reports (ICSRs), including serious adverse events (SAEs) and suspected unexpected serious adverse reactions (SUSARs), in compliance with applicable regulations

Oversee the set-up of new safety clinical studies, including development of study-specific Safety Management Plans and set-up of clinical studies in safety systems

Ensure adverse event data are accurately entered, coded, and reconciled in the safety database, and that case processing conventions and workflows are maintained

Apply knowledge of medical terminology and principles of clinical assessment to the evaluation of adverse events, including seriousness, causality, and expectedness, in collaboration with Medical/Safety Physicians

Oversee MedDRA coding of adverse events and medical history and manage dictionary version updates and coding conventions and quality

Select, manage, and oversee pharmacovigilance vendors and service providers, including contracting support, performance and quality metrics, issue escalation, and oversight of deliverables

Ensure compliance with applicable FDA, EU, UK (MHRA), and ICH requirements and guidelines for safety reporting and pharmacovigilance

Develop, review, and maintain pharmacovigilance SOPs, work instructions, safety management plans, and other controlled documents

Support the preparation and review of aggregate safety reports (e.g., DSURs) and contribute to safety-related sections of regulatory submissions and clinical documents as needed

Support safety data reconciliation with Data Management and vendors, and provide safety input to study-related documents, plans, and cross-functional team meetings

Support audit and inspection readiness activities, including preparation of documentation, responses to findings, and implementation of corrective and preventive actions (CAPAs)

Collaborate with colleagues in Biometrics, Clinical Development, Clinical Operations, Medical Affairs, and Regulatory Affairs to ensure patient safety and the integrity of safety data

Identify and implement process improvements, and track and report pharmacovigilance operational metrics to management

Required qualifications

BS or BA in a life sciences discipline required. Clinical experience (e.g., nursing or pharmacy background) preferred

A minimum of 6 years of pharmacovigilance experience in the pharmaceutical or biotechnology industry

High-level knowledge of relevant FDA, EU, UK, and ICH regulations and guidelines

Knowledge of medical terminology and principles of clinical assessment of adverse events in the pharmaceutical industry

Expertise in the MedDRA dictionary, with relevance to adverse event coding

Experience working with software-based drug safety systems (e.g. Argus, Veeva)

Experience in vendor management and oversight

Strong computer skills, including proficiency with Microsoft Office applications

Strong written and verbal communication, organizational, and problem-solving skills, with the ability to work effectively in a matrix environment and manage multiple priorities

Individual compensation within the range is determined based on factors such as relevant skills, experience, qualifications, scope of the role, and other legitimate business considerations. In addition to base salary, this role may be eligible for bonus and equity opportunities. We also offer a comprehensive benefits package including health insurance, 401(k) with company match, flexible time off and additional wellness benefits and perks. Learn more about our benefits on our Careers page.

The anticipated base salary range for this position is: $160,000 — $240,000 USD

Posting 6264044004 on greenhouse. Source: the employer’s listing. Valid through January 1, 2027 unless closed earlier.